These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 2906469)

  • 1. Hormonal regulation of gastric acid in peptic ulcer disease.
    Lamers CB
    Scand J Gastroenterol Suppl; 1988; 146():5-10. PubMed ID: 2906469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The significance of gastrin in the pathogenesis and therapy of peptic ulcer disease.
    Lamers CB
    Drugs; 1988; 35 Suppl 3():10-6. PubMed ID: 3061768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. G- and D-cell populations, serum and tissue concentrations of gastrin and somatostatin in patients with peptic ulcer diseases.
    Park SM; Park HS
    Korean J Intern Med; 1993 Jan; 8(1):1-7. PubMed ID: 7903552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antral gastrin and somatostatin concentrations in peptic ulcer patients.
    Sumii K; Fukushima T; Hirata K; Matsumoto Y; Sanuki E; Tsumaru S; Sumioka M; Miyoshi A; Miyachi Y
    Peptides; 1981; 2 Suppl 2():281-3. PubMed ID: 6123990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zollinger-Ellison syndrome and antral G-cell hyperfunction in patients with resistant duodenal ulcer disease.
    Annibale B; De Magistris L; Corleto V; D'Ambra G; Marignani M; Iannoni C; Delle Fave G
    Aliment Pharmacol Ther; 1994 Feb; 8(1):87-93. PubMed ID: 8186351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Omeprazole. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peptic ulcer disease and Zollinger-Ellison syndrome.
    Clissold SP; Campoli-Richards DM
    Drugs; 1986 Jul; 32(1):15-47. PubMed ID: 3527658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Present experiences with omeprazole in the Zollinger-Ellison syndrome.
    Lamers CB
    Scand J Gastroenterol Suppl; 1986; 118():123-8. PubMed ID: 3460167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of pirenzepine on omeprazole-induced hypergastrinemia and acid suppression in peptic ulcer patients.
    Tari A; Hamada M; Kamiyasu T; Fukino Y; Sumii M; Haruma K; Sumii K; Inoue M; Kajiyama G
    J Gastroenterol; 1996 Apr; 31(2):167-70. PubMed ID: 8680534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zollinger-Ellison syndrome. Advances in treatment of gastric hypersecretion and the gastrinoma.
    Jensen RT; Fraker DL
    JAMA; 1994 May; 271(18):1429-35. PubMed ID: 7513768
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-term treatment with lansoprazole for patients with Zollinger-Ellison syndrome.
    Hirschowitz BI; Mohnen J; Shaw S
    Aliment Pharmacol Ther; 1996 Aug; 10(4):507-22. PubMed ID: 8853754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of systemic gastric acid stimulation and intragastric pH changes on synchronous antral gastrin and somatostatin release in anesthetized, nonatropinized duodenal ulcer patients and controls.
    Ferahköşe Z; Altinyollar H; Menteş BB
    Dig Dis Sci; 1994 Oct; 39(10):2143-8. PubMed ID: 7924733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastric endocrine cell behavior in Zollinger-Ellison patients upon long-term potent antisecretory treatment.
    Lehy T; Mignon M; Cadiot G; Elouaer-Blanc L; Ruszniewski P; Lewin MJ; Bonfils S
    Gastroenterology; 1989 Apr; 96(4):1029-40. PubMed ID: 2925050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Idiopathic gastric acid hypersecretion presenting as a diarrheal disorder and mimicking both Zollinger-Ellison syndrome and Crohn's disease.
    Blonski WC; Katzka DA; Lichtenstein GR; Metz DC
    Eur J Gastroenterol Hepatol; 2005 Apr; 17(4):441-4. PubMed ID: 15756097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathological acid secretion not due to gastrinoma.
    Walsh JH; Nair PK; Kleibeuker J; Passaro EP; Deventer GV; Strom E; Rotter JI; Kauffman GL; Samloff IM; Lewin KJ
    Scand J Gastroenterol Suppl; 1983; 82():45-58. PubMed ID: 6579627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Studies on gastrin secretion in peptic ulcer -- changes in antral mucosal gastrin content in the course of peptic ulcer (author's transl)].
    Yamada N; Kumada H; Fukuchi S; Yanagishita M; Shishiba Y; Yamazaki Y; Hara M
    Nihon Shokakibyo Gakkai Zasshi; 1981 Jun; 78(6):1198-208. PubMed ID: 7277808
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term treatment with lansoprazole of patients with duodenal ulcer and basal acid output of more than 15 mmol/h.
    Hirschowitz BI; Mohnen J; Shaw S
    Aliment Pharmacol Ther; 1996 Aug; 10(4):497-506. PubMed ID: 8853753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in drug therapy for peptic ulcer disease.
    Pappas TN; Mulvihill SJ; Goto Y; Debas HT
    Arch Surg; 1987 Apr; 122(4):447-50. PubMed ID: 2882741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antral gastrin cell hyperfunction in children. A functional and immunocytochemical report.
    Annibale B; Bonamico M; Rindi G; Villani L; Ferrante E; Vania A; Solcia E; Delle Fave G
    Gastroenterology; 1991 Dec; 101(6):1547-51. PubMed ID: 1683324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton-pump inhibition for acid-related disease.
    Holt S
    South Med J; 1991 Sep; 84(9):1078-87. PubMed ID: 1653998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antral gastrin-producing G-cells and somatostatin-producing D-cells in different states of gastric acid secretion.
    Arnold R; Hülst MV; Neuhof CH; Schwarting H; Becker HD; Creutzfeldt W
    Gut; 1982 Apr; 23(4):285-91. PubMed ID: 6122629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.